Home › Research › Disease mechanisms
Brain organoids in Alzheimer disease and related tauopathies: Challenges and opportunities for translational readiness
Anuj Guruacharya, Thomas Härtung, Roberta Sena Reis, Natália Chermont dos Santos Moreira, Liliana Attisano, Silvia Bolognin, Khalid Iqbal, Binita Rajbanshi. Stem Cell Reports, 2026-08-20
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
A major hurdle in Alzheimer disease research is the failure of mouse models to capture complexities of the human brain that contributes to repeated clinical trial failure. Although the recent US Food and Drug Administration (FDA) Modernization Act 2.0 has enabled non-animal preclinical pathways, brain organoid models of tauopathies remain nascent compared with other disease areas. Here, we identify three challenges for their translational readiness, maturity, disease-relevant cellular complexity, and pathological accuracy, and examine current achievements and emerging solutions. We propose a ten-metric benchmarking framework and discuss the opportunities and remaining challenges for translational readiness in tauopathy modeling.
What this study adds
Evidence grade: Low
This paper discusses the challenges of using brain organoid models for Alzheimer's disease and related tauopathies and proposes a benchmarking framework for making them more translationally useful. It is a methods and modeling discussion and does not report any treatment, cure, or prevention for patients.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Guruacharya, A., Härtung, T., Reis, R. S., Moreira, N. C. d. S., Attisano, L., Bolognin, S., et al. (2026). Brain organoids in Alzheimer disease and related tauopathies: Challenges and opportunities for translational readiness. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2026.103051
Vancouver
Guruacharya A, Härtung T, Reis RS, Moreira NCdS, Attisano L, Bolognin S, et al. Brain organoids in Alzheimer disease and related tauopathies: Challenges and opportunities for translational readiness. Stem Cell Reports. 2026. doi:10.1016/j.stemcr.2026.103051. PMID: 42624102.
BibTeX
@article{guruacharya2026-42624102,
author = {Guruacharya, Anuj and Härtung, Thomas and Reis, Roberta Sena and Moreira, Natália Chermont dos Santos and Attisano, Liliana and Bolognin, Silvia and Iqbal, Khalid and Rajbanshi, Binita},
title = {{Brain organoids in Alzheimer disease and related tauopathies: Challenges and opportunities for translational readiness}},
journal = {Stem Cell Reports},
year = {2026},
doi = {10.1016/j.stemcr.2026.103051},
pmid = {42624102},
url = {https://doi.org/10.1016/j.stemcr.2026.103051}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Although the recent US Food and Drug Administration (FDA) Modernization Act 2.0 has enabled non-animal preclinical pathways, brain organoid models of tauopathies remain nascent compared with other disease areas.
Why it matters
This paper discusses the challenges of using brain organoid models for Alzheimer's disease and related tauopathies and proposes a benchmarking framework for making them more translationally useful. It is a methods and modeling discussion and does not report any treatment, cure, or prevention for patients.
Study details
- Evidence strengthLow
How this study scored 42/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 27 of the 64 points we could judge it on, which is 42 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Stem Cell Reports) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Laboratory or animal study (title names “organoids”) — scores zero |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42624102) |
| Free to read | 2 / 2 | Free to read |
| Points | 27 / 64 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 27 of the 64 points we could judge it on is 42 out of 100. |
| Total | 42 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Disease mechanisms from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.